Clinical Trials Sponsored by Medinova AG

Total 2397 results

Kay van Heeswijk
CPM Sport AG Bern

Active, not recruiting

Non-invasive Measurement of Compartment Pressure: Reliability

CEC Syndrome

Netherlands
BioVersys AG
CRU Hungary Kft; CRU Hungary Early Phase Unit

Completed

Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment

Renal Impairment

Hungary
West German Center of Diabetes and Health
gbo Medizintechnik AG

Completed

HTEMS Treatment of Diabetic Polyneuropathy (HTEMS-RCT)

Diabetic Polyneuropathy

Germany
LimmaTech Biologics AG
Johns Hopkins Bloomberg School of Public Health

Completed

Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a

Shigellosis

United States
University of Padova, School of Dental Medicine
Geistlich Pharma AG

Completed

Deproteinized Bovine Bone in Alveolar Bone Critical Size Defect (>2cm) Secondary to Cyst Removal

Maxillary Cyst
West German Center of Diabetes and Health
gbo Medizintechnik AG

Completed

High-tone External Muscle Stimulation for Pain Reduction (HTEMS)

Chronic Radicular Back Pain | Lumboischialgia | Cervico Brachialgia

Germany
Manuela Eicher
Swiss Cancer League; Lindenhofgruppe AG

Completed

Testing of the Cancer Thriving and Surviving Breast Cancer Program (COSS)

Breast Neoplasm | Self-Management | Intervention | Cancer Survivorship | Early-Stage Breast Cancer

Switzerland
Deok-Hwan Yang
Roche Pharma AG

Unknown

A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment

Chronic Lymphocytic Leukemia

Korea, Republic of
German CLL Study Group
Mundipharma Pte Ltd.; Roche Pharma AG

Completed

FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Germany
Medical University of Warsaw
Ivoclar Vivadent AG; Wroclaw Medical University

Unknown

Efficacy of Fluor Protector S in the Prevention in Adolescents

Dental Caries | Fluor

Poland
Lund University Hospital
Mundipharma Pte Ltd.; Roche Pharma AG; Celgene

Completed

Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma. (LENA-BERIT)

Mantle Cell Lymphoma

Finland, Denmark, Norway, Sweden
University Hospital, Tours
Roche Pharma AG; French Innovative Leukemia Organisation

Completed

Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia (LLC2007SA)

Leukemia

France
Gesellschaft fur Medizinische Innovation - Hamatologie...
iOMEDICO AG

Completed

Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment (PASO)

Metastatic Breast Cancer

Germany
Ralf Degenhardt, PhD
B. Braun Melsungen AG

Completed

The Paclitaxel-Eluting Percutaneous Coronary Angioplasty (PTCA)-Balloon Catheter for the Treatment of Coronary Bifurcations (PEPCAD-BIF)

Angioplasty

Germany
German Breast Group
GlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USA

Completed

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (GeparSixto)

Inflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IV

Germany
IPSC AG
Medical University of Graz; Sciotec Diagnostic Technologies GmbH

Completed

A Provocation Study Using Biogenic Amines to Show the Efficacy of Oral Diamine Oxidase Supplementation

Histamine Intolerance

Austria
TME Pharma AG
German Federal Ministry of Education and Research

Completed

NOX-A12 First-in-human (FIH) Study

Autologous Stem Cell Transplantation

Germany
University of Texas Southwestern Medical Center
Roche Pharma AG; Biogen

Completed

Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis

Multiple Sclerosis

United States
Jean-Luc Van Laethem
Roche Pharma AG

Unknown

Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer (NEOPACHI-001)

Pancreatic Adenocarcinoma Resectable

Belgium
The HIV Netherlands Australia Thailand Research...
Roche Pharma AG

Completed

Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r

HIV Infections

Thailand
Insel Gruppe AG, University Hospital Bern
Psychiatric University Hospital, Zurich

Recruiting

Molecular Imaging Study of Harmine/DMT: a Basic Research Approach (HaD-PET)

Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Recruiting

Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control (ParOP)

Pain

Switzerland
Assistance Publique - Hôpitaux de Paris
Roche Pharma AG; Roche Chugai

Recruiting

Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement (TOGIAC)

Giant Cell Arteritis | Neurovascular Disorder

France
SOTIO Biotech AG
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Hepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Castration-resistant Prostate Cancer | Cutaneous Squamous Cell Carcinoma

Italy, Spain, France, Belgium, Czechia, United States, Poland, Georgia, Hungary
Ivoclar Vivadent AG
Iuliu Hatieganu University of Medicine and Pharmacy

Active, not recruiting

Clinical Evaluation of an Experimental Remineralization Product

White Spot Lesion

Romania
University Medical Center Groningen
Insel Gruppe AG, University Hospital Bern

Completed

Utility of the Smart Pilot View in Clinical Practice: A Two Center Prospective Observational Study

Anesthesia,General

Netherlands, Switzerland
crossklinik AG
Basel Academy for Quality and Research in Medicine

Completed

Comparing a Sensor for Movement Assessment With Traditional Clinical Assessment Methods in Patients After Knee Surgery. (MA-KNEE)

Status After Knee Surgery

Switzerland
Lia Bally
ETH Zurich

Active, not recruiting

How Altered Gut-Brain-Axis Influences Food Choices: Part 2 (BrainFood) (BrainFood)

Obesity | Food Preferences

Switzerland
The Netherlands Cancer Institute
Roche Pharma AG; Borstkanker Onderzoek Groep

Active, not recruiting

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 (TRAIN-2)

Breast Cancer | HER2 Positive

Netherlands
Gaia AG
Hannover Medical School; Universitätsklinikum Schleswig-Holstein, Campus Kiel

Active, not recruiting

Evaluating the Effectiveness of a Digital Therapeutic (Reviga) for People With Stress or Burnout (LAVENDER)

Stress | Burnout

Germany
Sonova AG
The State University of New York at Buffalo

Completed

Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

Hearing Loss, Sensorineural | Tinnitus

United States
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Completed

Digitalized Differential Diagnosis Broadening in Emergency Rooms (DDX-BRO)

Emergencies | Diagnoses Disease

Switzerland
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Completed

Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function (SERVE)

Heart Defects, Congenital | Transposition of Great Vessels With Ventricular Inversion

Switzerland, Austria
Sucampo Pharma Americas, LLC
Sucampo AG; Sucampo Pharmaceuticals, Inc.

Completed

Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo

Chronic Idiopathic Constipation

United States
Rennes University Hospital
Roche Pharma AG; National Research Agency, France

Completed

BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology (BMS_PD-L1)

Hodgkin Lymphoma | Non-small Cell Lung Cancer | Diffuse Large B-cell Lymphoma | Metastatic Breastcancer

France
Bio-Strath AG
Zentrum für Adipositas- und Stoffwechselmedizin Winterthur GmbH

Unknown

Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women

Overweight

Switzerland
University Hospital Inselspital, Berne
Roche Pharma AG; University of Bern

Completed

Tocilizumab for Patients With Giant Cell Arteritis

Giant Cell Arteritis

Switzerland
National Center for Tumor Diseases, Heidelberg
Heidelberg University; iOMEDICO AG

Unknown

Effects of ECA on Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades (SUPPORT)

Pain

Germany
Jinming Yu
Roche Pharma AG

Unknown

Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21 (RECEL)

Non-small Cell Lung Cancer

China
Ralf Degenhardt, PhD
B. Braun Melsungen AG

Completed

INDICOR The Paclitaxel-Eluting PTCA-Balloon Catheter in Combination With a Cobalt-Chromium Stent (INDICOR)

Coronary Heart Diseases

India
National Bone Health Alliance
Roche Pharma AG; National Osteoporosis Foundation

Unknown

Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates

Osteoporosis

United States
University Hospital, Basel, Switzerland
University of Basel; Solothurner Spitäler AG

Completed

Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin

Diabetes Mellitus Type 2

Switzerland
Aktion Bronchialkarzinom e.V.
Eli Lilly and Company; Roche Pharma AG

Withdrawn

TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV (SELECT-A)

Carcinoma, Non-Small-Cell Lung
University of Minnesota
Juvenile Diabetes Research Foundation; Roche Pharma AG

Completed

Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

United States
Sensimed AG
Private practicioner, Dr Sunaric Mégevand; Orasis, AugenZentrum Pajic

Terminated

Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma Patients

Pigmentary Dispersion Syndrome | Pigmentary Glaucoma Patients

Switzerland
Salvador Gil-Vernet
Roche Pharma AG

Completed

Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

Cytomegalovirus Infection

Spain
Centre Hospitalier Universitaire, Amiens
Roche Pharma AG; Astellas Pharma Inc

Completed

TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic

Kidney Transplantation

France
Gaia AG
University Hospital, Aachen; Deutsche Stiftung für chronisch Kranke

Not yet recruiting

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels (DIGICHOL)

Dyslipidemias | Hypercholesterolemia

Germany
Insel Gruppe AG, University Hospital Bern
Sahajanand Medical Technologies Limited

Recruiting

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation (MATRIX-2)

Atrial Fibrillation (AF) | Oral Anticoagulation | Percutaneous Coronary Intervention (PCI) | P2Y12 Inhibitor

Spain, France, Switzerland, United Kingdom, Germany, Belgium, Italy, Netherlands, Poland
University Hospital Inselspital, Berne
University of Bern; Haag-Streit AG

Not yet recruiting

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI) (STARFLI)

Retinal Disease

Switzerland

Clinical Trials Sponsored by Medinova AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations